GEHC — GE HealthCare Technologies Inc. Common Stock price, chart and key statistics

Price data

Price

$63.93

Change YTD

-21.94%

Next earnings

Nov 4, 2026

Market cap

29.1B2022-12 26.5B2026-09 29.1B+9.7% over the window

Enterprise value

39.4B

Shares outstanding

454.9M2021-12 454M2026-03 454.9M+0.2% over the window

52W low

$58.75

52W high

$89.77

From 52W high

-28.78%

From 52W low

+8.82%

52W range

17%

Beta

0.80

Volume

Rel volume

0.81×

30D volume

2.9M

30D $ vol

203.8M

Fundamentals

Sales (ttm)

21B2021-12 17.6B2026-03 21B+19.3% over the window

Sales/share

$46.122021-12 $38.732026-03 $46.12+19.1% over the window

EPS (ttm)

$4.172021-12 $4.952026-03 $4.17-15.7% over the window

FCF (ttm)

1.5B2021-12 1.4B2025-12 1.5B+10.7% over the window

FCF/share

$3.312021-12 $2.992025-12 $3.30+10.3% over the window

Book value/share

$23.452021-12 $36.732026-03 $23.45-36.2% over the window

Net margin

9.10%2021-12 12.8%2026-03 9.1%-28.7% over the window

ROE

17.90%2021-12 13.5%2026-03 17.9%+32.9% over the window

ROA

5.14%2022-12 7.0%2026-03 5.1%-26.1% over the window

Debt / equity

0.95×2022-12 0.882026-03 0.95+7.9% over the window

Current ratio

1.222022-12 1.162026-03 1.22+5.7% over the window

Growth (CAGR, ttm) · 10Y

Sales

+5.97%2025-03-31 → 2026-03-3119.8B → 21B (+6.0% total)+3.90%2023-03-31 → 2026-03-3118.7B → 21B (+12.2% total)n/an/a

Net income

-12.51%2025-03-31 → 2026-03-312.2B → 1.9B (-12.5% total)+0.21%2023-03-31 → 2026-03-311.9B → 1.9B (+0.6% total)n/an/a

FCF

-3.16%2024-12-31 → 2025-12-311.6B → 1.5B (-3.2% total)-6.21%2022-12-31 → 2025-12-311.8B → 1.5B (-17.5% total)n/an/a

Shares

-0.65%2025-03-31 → 2026-03-31457.9M → 454.9M (-0.7% total)+0.02%2023-03-31 → 2026-03-31454.7M → 454.9M (+0.0% total)n/an/a

Per-share growth (CAGR, ttm) · 10Y

EPS

-12.23%2025-03-31 → 2026-03-31$4.76 → $4.17 (-12.2% total)+0.01%2023-03-31 → 2026-03-31$4.17 → $4.17 (+0.0% total)n/an/a

Sales/share

+6.67%2025-03-31 → 2026-03-31$43.24 → $46.12 (+6.7% total)+3.88%2023-03-31 → 2026-03-31$41.14 → $46.12 (+12.1% total)n/an/a

FCF/share

-2.83%2024-12-31 → 2025-12-31$3.40 → $3.30 (-2.8% total)-6.33%2022-12-31 → 2025-12-31$4.02 → $3.30 (-17.8% total)n/an/a

Book value/share

+16.90%2025-03-31 → 2026-03-31$20.06 → $23.45 (+16.9% total)+16.81%2023-03-31 → 2026-03-31$14.71 → $23.45 (+59.4% total)n/an/a

Dividend/share

+7.70%2025-03-31 → 2026-03-31$0.13 → $0.14 (+7.7% total)+73.42%2023-06-30 → 2026-03-31$0.03 → $0.14 (+354.8% total)n/an/a

Price

-18.01%2025-09-11 → 2026-09-11$77.96 → $63.93 (-18.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.36%2023-09-11 → 2026-09-11$66.62 → $63.93 (-4.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/an/a

Total return

-17.85%2025-09-11 → 2026-09-11$77.81 → $63.93 (-17.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.19%2023-09-11 → 2026-09-11$66.27 → $63.93 (-3.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

15.3×2022-12 11.802026-09 15.23+29.1% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

11.0×2022-12 9.482026-09 10.98+15.8% over the window

Fwd P/E

12.4×

P/S (ttm)Market cap ÷ TTM revenue.

1.4×2022-12 1.512026-09 1.39-8.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

2.7×2022-12 1.572026-09 2.73+73.6% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

19.3×2022-12 19.502026-09 19.32-0.9% over the window

EV/EBITDA (fy)

12.1×

EV/Sales (ttm)

1.9×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

5.18%2022-12 6.9%2025-12 4.0%-41.5% over the window

Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.

0.22%

Dividend/share (fwd)

$0.14

Buyback yield (realized, 1y)1 − shares_at(2026-03-31) ÷ shares_at(2025-03-31) = 1 − 454.9M ÷ 457.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

0.65%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (0.65%) + dividends paid over that year ($64M) ÷ market_cap_at(2025-03-31) ($37B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

0.83%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($300M) ÷ today's market cap ($29.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

1.03%2022-12 0.0%2026-03 0.9%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $300M + TTM dividends $64M) ÷ today's market cap ($29.1B). Same caveat as the cash buyback yield.

1.25%2022-12 0.0%2026-03 1.1%

Vs own 10Y history

P/E

17th

P/OI

7th

P/S

4th

P/B

5th

P/FCF

24th